Angiogenesis and hematopoiesis are closely linked and interactive with each other, but few studies were given to identify possible links between angiogenesis-promoting proteins and hematopoiesis-related transcription factors. Here we investigated the potential relationship of oxygensensitive a-subunit of angiogenesis-related hypoxiainducible factor-1a (HIF-1a) with Runt-related protein 1 (Runx1, also known as acute myeloid leukemia-1, AML-1), an important hematopoietic transcription factor. The results demonstrated that Runx1 and HIF-1a proteins directly interacted with each other to a degree, in which Runt homology domain of Runx1 was mainly involved. Leukemia-related abnormal Runx1 fusion protein AML1-ETO, which fuses the N-terminal 177 amino acid residues of the Runx1 protein in frame to ETO (eight-twenty-one) protein, also interacted with HIF-1a protein with greater ability than Runx1 itself. More intriguingly, Runx1 overexpression inhibited DNA-binding and transcriptional activity of HIF-1 protein with reduced expression of HIF-1-targeted genes such as vascular endothelial growth factor, while silence of Runx1 expression by specific small interfering RNA significantly increased transcriptional activity of HIF-1 protein, suggesting that Runx1 inhibited transcription-dependent function of HIF-1. Vice versa, HIF-1a increased DNA-binding ability and transcriptional activity of Runx1 protein. All these data would shed new insight to understanding Runx1 and HIF-1a-related hematopoietic cell differentiation and angiogenesis.
Introduction
Angiogenesis, an essential process during development and diseases such as solid tumors, cardiovascular diseases and chronic inflammation (Folkman and Shing, 1992; Griffioen and Molema, 2000; Kilic et al., 2007) , is induced by hypoxic condition, which is regulated by the hypoxia-inducible factor-1 (HIF-1) (Hirota and Semenza, 2006) . This heterodimeric transcription factor is composed of the oxygen-sensitive HIF-1a and the constitutively presented HIF-1b subunits. The HIF-1a protein contains two highly conserved and independent yet interactive prolines, which are hydroxylated by HIF1a-specific prolyl hydroxylases (HPHs) (Chan et al., 2005) . The hydroxylated HIF-1a protein interacts with the von Hippel-Lindau (VHL) E3 ubiquitin ligase, thus targeting HIF-1a protein to the proteasome for its degradation (Alberghini et al., 2005) . Because HPHs require oxygen, iron and 2-oxoglutarate as cofactors, depletion of oxygen (hypoxia) and treatment of cobalt chloride (CoCl 2 ) or the iron chelator such as desferrioxamine inhibit the enzymatic activity and cause stabilization of HIF-1a protein (Maxwell et al., 1999; Chan et al., 2005) . The stabilized HIF-1a protein is translocated into the nucleus, followed by heterodimerization with HIF-1b (also known as aryl hydrocarbon receptor nuclear translocator, ARNT) subunit. Consequently, HIF-1 heterodimer binds to the hypoxia-responsive element (HRE; 5 0 -RCGTG-3 0 ) and activates transcription of an impressive array of genes such as erythropoietin (Epo), vascular endothelial growth factor (VEGF) and glucose transporter-1 (Glut-1) (Pugh and Ratcliffe, 2003; Manalo et al., 2005) .
Vascular and hematopoietic systems must develop together to establish the body's oxygen-delivery system during organogenesis. As discussed (Suda et al., 2000) , angiogenesis and hematopoiesis, which have common ancestors (hemangioblasts or hematogenic endothelial cells), are closely linked and interactive with each other. Hematopoietic process is closely regulated by a series of transcription factors such as Runt-related protein 1 (Runx1, also called as acute myeloid leukemia-1, AML-1), CCAAT/enhancer-binding proteins (C/EBPs), PU.1 and others (Werner et al., 1999; Friedman, 2002) . More intriguingly, hematopoiesis-related Runx1 was also shown to play an important role in angiogenesis (Namba et al., 2000; Aikawa et al., 2006) . On the other direction, hypoxia or HIF-1 also modulates normal and malignant hematopoietic differentiation (Desplat et al., 2002; Jiang et al., 2005; Liu et al., 2006; Nguyen-Khac et al., 2006) . In the past, to our greatest understanding, few studies were given to identify the possible link between angiogenesis-promoting HIF-1 and hematopoiesis-related transcription factors. In this work, we first demonstrated the physical and functional interaction between Runx1 and HIF-1a.
Results

Runx1 physically interacts with HIF-1a protein
To test whether Runx1 and HIF-1a proteins physically interact with each other, stable A03_1 cell line was employed. This cell line contains integrated Lac operator (LacO) heterochromatic array (Li et al., 1998) and has been used to evaluate protein-protein interaction in the context of chromatin ( Figure 1A ) (Stenoien et al., 2001) . Briefly, stable A03_1 cell line was transfected by yellow fluorescent protein (YFP)-Runx1 and/or cyan fluorescent protein (CFP)-LacR-HIF-1a. In consistence with the previous report (Odaka et al., 2000) , singly expressed YFP-Runx1 protein was diffusely distributed into nuclei (Figure 1Ba ), while singly expressed CFP-LacR-HIF-1a protein was localized into the array in the global appearance like that seen in Figure 1Bb . At co-transfection of these two proteins, part of YFP-Runx1 protein was recruited together with CFP-LacR-HIF-1a protein into the global array ( Figure   1Bc ), suggesting the presence of interaction of Runx1 and HIF-1a proteins to some extent, although some YFP-Runx1 protein was still dispersed into nuclei. To validate such an interaction, co-immunoprecipitation (Co-IP) experiments were performed in Cos-7 and HeLa cells with co-transfection of Flag-Runx1 and HIF-1a. Both cell lines had undetectable endogenous Runx1 protein, while Cos-7 but not HeLa cell line displayed detectable HIF-1a protein with HIF-1a transfection under normoxic condition. The results showed that part of Flag-Runx1 protein could be co-precipitated with HIF-1a by anti-HIF-1a antibody. Vice versa, some HIF-1a protein was also pulled down together with Flag-Runx1 protein by anti-Flag antibody (Supplementary Figure S1) . Moreover, glutathione S-transferase (GST) pull-down assay also showed that Escherichia coli BL21-expressing GST-Runx1 fusion protein significantly pulled down the in vitro translated HIF-1a protein but GST alone did not (Figure 2a) , suggesting a direct physical interaction of Runx1 and HIF-1a proteins.
All experiments performed above strongly supported that Runx1 and HIF-1a proteins interact with each other to a degree. Furthermore, potential interaction of Runx1 with HIF-1a protein was also detected in leukemic U937 cells, which expressed endogenous Runx1 protein with three isoforms and also had detectable HIF-1a protein in the presence of hypoxiamimetic reagent CoCl 2 at 100 mM ( Figure 3a) . As can be visualized in Figure 3b , precipitates of nuclear extract of The results demonstrated that Runx1, ETO or AML1-ETO protein (right panel, Figure 4a ) was overexpressed, and transfected HIF-1a protein could also be clearly seen in 95% air (left panel, Figure 4a ), indicating the effective transfection. In the Co-IP experiments, preimmune mouse serum failed to precipitate either HIF-1a or Flag-tagged protein (Figure 4b ), while anti-HIF-1a antibody could precipitate HIF-1a protein (left panel, Figure 4c ) and anti-Flag antibody could precipitate Flag-ETO and Flag-AML1-ETO proteins (right panel, Figure 4d ). Because Flag-Runx1 protein and heavy chain of anti-Flag IgG had nearly the same MW to be well distinguished from each other (lanes 3 and 7, right panel, Figure 4d ), the blot was stripped and reprobed by anti-Runx1 antibody, which supported the precipitation of Flag-Runx1 and Flag-AML1-ETO by anti-Flag antibody ( Figure 4e ). In addition, anti-HIF-1a antibody did not precipitate Flag peptide, and anti-Flag antibody failed to pull down HIF-1a protein in CMV4-transfected cells (Figures 4c and d) , ruling out the possibility of interaction between HIF-1a protein and Flag peptide. Based on these control experiments that supported the specificity of Co-IP test used here, the results revealed Figure 2 Glutathione S-transferase (GST) pull-down assay shows that direct interaction of hypoxia-inducible factor-1a (HIF-1a) with Runt-related protein 1 (Runx1). (a) Escherichia coli BL21-expressing GST and GST-Runx1 (a) and/or GST-Runx1 domains (b) were purified and blotted with anti-GST antibody. Equal amounts of purified proteins were incubated with the in vitro translated HIF-1a protein, and then the GST pulled-down complexes were blotted by anti-HIF-1a antibody. The top of (b) is schematic illustration of functional domains of Runx1. that Flag-AML1-ETO protein could also be co-precipitated with HIF-1a by anti-HIF-1a antibody (Figure 4c ). Vice versa, HIF-1a protein could be co-precipitated with Flag-Runx1/AML1-ETO proteins (Figure 4d ). AML1-ETO had stronger HIF-1a-binding ability than Runx1, more intriguingly, because anti-HIF-1a antibody could even pull down more AML1-ETO than Runx1 protein (lane 9 vs 7 of right panel, Figure 4c ), and Flag-AML1-ETO precipitated more HIF-1a protein than Flag-Runx1 (lane 9 vs 7 of left panel, Figure 4d ). Unlike Runx1 and AML1-ETO, by the way, ETO did not co-precipitate with HIF-1a (Figures 4c and d) . These experiments appeared to support that N-terminus of Runx1 protein contributes to its interaction with HIF-1a protein. Because a fusion gene product often exhibits a unique structure and biological activity, GST pull-down assay was applied to test the potential interaction of HIF-1a with six Runx1 domains, that is N-terminus, RHD, negative regulatory region of DNA binding (NRDB), activation domain (AD), inhibitory domain (ID) and C-terminus of Runx1 (Figure 2b ). The results showed that, like full-length Runx1 (residues 1-480), RHD domain (residues 87-204) of Runx1 pulled down HIF-1a. Of note, ID domain (residues 398-438) of Runx1 could also bind with HIF-1a protein with a lower ability than RHD domain.
HIF-1a enhances transcriptional activity of Runx1
In the next phase of analysis, electrophoretic gel mobility shift assay (EMSA) was used to test whether Runx1 and HIF-1a impact their DNA-binding abilities. The results showed that Runx1 inhibited HIF-1a binding to HRE probe, while 2% air treatment enhanced DNA-binding ability of Runx1 (Supplementary Figure S2 ). Hence, we investigated whether HIF-1a impinges on transcriptional activity of Runx1. HeLa cells were transfected with Runx1 and/or HIF-1a-expressing vectors together with core-binding factor-b (CBF-b, a partner of Runx1 for its basic activity (Friedman, 2002) ), the human macrophage colonystimulating factor receptor (M-CSFR) promoter (-416 to þ 71)-driven luciferase (M-CSFR-Luc, which contains Runx1-binding sites ) and pSV40-renilla. Twenty-four hours later, cells were incubated in 95 or 2% air for additional 24 h. As mentioned above, HeLa cells expressed undetectable Runx1 and HIF-1a proteins in 95% air, regardless of HIF-1a transfection (Figure 5a , lanes 1 and 2), whereas 2% air induced HIF-1a protein accumulation (Figure 5a , lanes 5 and 7), especially in cells transfected with HIF-1a (Figure 5a , lanes 6 and 8). Of note, ectopic expression of Runx1 was not impacted by 2% air with or without HIF-1a transfection, and in a reciprocal manner, HIF-1a expression was not influenced by Interaction of Runx1 with HIF-1a ZG Peng et al Runx1 overexpression. In consistence with the previous reports , Runx1 dramatically increased M-CSFR-Luc activity in 95% air (B10-folds, Figure 5a , lane 3). In comparison with 95% air, 2% air increased M-CSFR-Luc activity driven by Runx1 to some extent (P ¼ 0.031, Figure 5a , lane 3 vs 7). Of great importance, HIF-1a transfection significantly enhanced Runx1-induced M-CSFR-Luc activity in hypoxia (P ¼ 0.009, Figure 5a , lane 7 vs 8). These data noted that HIF-1a enhances transcriptional activity of Runx1. Consistent with this notion, 2% air, which induced HIF-1a protein stabilization, significantly upregulated the expressions of M-CSFR, CD11c and cyclin D3, the three known Runx1 target genes (Bernardin-Fried et al., 2004) , in endogenous Runx1-expressing leukemic U937 cell line (Figure 5b ).
Runx1 inhibits transcriptional activity of HIF-1a protein
We also explored whether Runx1 impinges on transcriptional function of HIF-1a protein by detecting HRE-driven luciferase activity and mRNA levels of HIF-1-targeted genes VEGF and Glut-1. For the detection of HREdriven Luc activity, HeLa cells were co-transfected with Runx1-expressing vector together with EpoHRE-Luc plasmid, a luciferase reporter construct containing four HREs of the Epo gene (Ema et al., 1997) and pSV40-renilla. Then, the cells were incubated in 95 or 2% air. The results showed that the stabilization of HIF-1a protein by 2% air significantly increased the relative EpoHRE-Luc activity and transcription of VEGF/Glut-1, all of which were significantly inhibited by Runx1 overexpression (Figure 6a ). Furthermore, U937 cells were stably transfected with three specific small interfering RNAs (siRNAs) against Runx1 (A1, A2 and A3) respectively with negative vector (NC) as control. Forty-eight hours later, the stable transfected cells were selected by 500 mg/ml of G418. The results revealed that A2-transfected cells presented significantly lower Runx1 expression than NC and other two Runx1-siRNA-transfected cells (Figure 6b and data not shown). Thus, U937 cells with stable transfections of NC, A1 and A2 were treated with or without 2% air for 24 h, and then relative VEGF and Glut-1 mRNA levels were measured by real-time quantitative RT-PCR. As depicted in Figure 6b , 2% air increased the transcription of VEGF and Glut-1 in NC cells. A1 cells, which had normal Runx1 expression, presented the similar VEGF and Glut-1 mRNA levels under hypoxia, whereas suppression of Runx1 expression in A2-transfected cells significantly enhanced mRNA levels of VEGF and Glut-1, compared with hypoxic NC cells.
Discussion
To date, some important HIF-1a-interacting proteins have been identified, such as VHL, p14 ARF (Fatyol and Szalay, 2001 ) and factor-inhibiting HIF-1 (FIH-1) (Mahon et al., 2001) , which regulate protein stability and transcriptional activity of HIF-1. More recently, HIF-1a was also shown to interact with and antagonize transcriptional activity of Myc protein in a manner Interaction of Runx1 with HIF-1a ZG Peng et al independent of the DNA binding/transcriptional ability of HIF-1 protein (Koshiji et al., 2004) . In this work, we showed that ectopically expressing Runx1 protein could directly interact with HIF-1a protein to a degree, as determined by LacO array, Co-IP and GST pull-down assay. Such an interaction could also be seen in endogenously expressed Runx1 and CoCl 2 -stabilized HIF-1a protein, which excluded the possibility of artifact in transfected cells. By GST pull-down assay, we also showed that RHD domain, which is responsible for binding to the consensus sequence of the promoters of Runx1-targeted genes and for the formation of heterodimeric complex with its partner protein CBF-b (Nuchprayoon et al., 1994; Chevallier et al., 2004) , and inhibitory domain of Runx1 protein were involved in this interaction. Because Runx1-derived leukemic fusion protein AML1-ETO also carries RHD of Runx1 protein, we further detected whether the fusion protein binds to HIF-1a protein by Co-IP assay. The results showed that AML1-ETO effectively interacted with HIF-1a protein, but ETO protein failed. It deserved to point out that AML1-ETO appeared to have stronger HIF-1a-binding ability than its wild-type partner Runx1 protein. Therefore, it remains to be investigated whether ETO moiety would enhance HIF1a-binding ability of AML1-ETO protein. This reminded us of the fact that transcription activation of the antiapoptotic BCL-2 gene by AML1-ETO, but not Runx1 in U937 cells, requires the presence of both the runt domain and the C-terminal portion of AML1-ETO (Klampfer et al., 1996) .
More recently, hypoxia/HIF-1a is reported to induce differentiation of AML cells and enhances the granulocytic differentiation of normal hematopoietic cell line 32Dcl3 (Huang et al., 2003; Jiang et al., 2005; Liu et al., 2006; Nguyen-Khac et al., 2006) . Recently, we also proposed that HIF-1a-induced leukemic cell differentiation is independent of its transcriptional activity (Song et al., 2007) . Herein, we showed that, consistent with that Runx1 inhibited DNA-binding activity of HIF-1 protein, Runx1 overexpression inhibited transcriptional activity of HIF-1 protein, which was conversely significantly increased by the specific siRNA-suppressing Runx1 expression. These results proposed that Runx1 inhibited transcription-dependent function of HIF-1 through their direct interaction. Accordingly, we extrapolate that Runx1 expression in hematopoietic cells should inhibit hypoxia-induced angiogenesis by antagonizing transcriptional function of HIF-1 protein, which is good for low-oxygen microenvironment of bone marrow. On the other hand, we also found that HIF-1a enhanced DNA-binding ability of Runx1. In agreement, HIF-1a (a) HeLa cells were transfected by pFlag-CMV4 (vehicle) or pFlag-CMV4-Runx1 (Runx1) together with pGL3-EpoHRE-Luc and pSV40-Renilla. Twenty-four hours later, the cells were incubated in 95 or 2% air for additional 24 h. Cell lysates were analysed for relative Luc activity and relative vascular endothelial growth factor (VEGF)/glucose transporter-1 (Glut-1) mRNA levels were determined by real-time quantitative RT-PCR. The relative hypoxia-responsive element luciferase (HRE-Luc) activities were normalized by pSV40-Renilla and increased folds were calculated against vehicle cells in 95% air. Western blot with indicated antibodies was also shown in the bottom. Symbols * and # represent P-values respectively against vehicle cells in 95 and 2% air. (b) U937 cells stably transfected with negative control (NC) and small interfering RNAs (siRNAs) against Runx1 (A1 and A2) were treated with or without 2% air for 24 h. Then relative vascular endothelial growth factor (VEGF)/glucose transporter-1 (Glut-1) mRNA levels were measured. Western blot showed Runx1 protein level of these stable transfected cell lines. Symbols * and # represent P-values respectively against NC in 95 and 2% air. All experiments were repeated for three times with each triplicate in an independent test and data represent means7s.d. of all experiments. expression also enhanced transcriptional activity of Runx1. It should be pointed out that Runx1 seems to be a relatively weak activator of transcription, given that DNA binding of Runx1/CBF-b on its own is necessary but insufficient to exert full activation of gene transcription (Durst and Hiebert, 2004) . Thus, it was proposed that Runx1 functions as an organizing protein that facilitates assembly of transcriptional activation complexes (Kurokawa and Hirai, 2003) . In agreement, Runx1-binding sites are frequently adjacent to binding sites of other hematopoietic transcription factors such as Ets-1, Myb and C/EBPa within several target gene promoters (Kurokawa and Hirai, 2003) . All these factors are known to cooperate with Runx1 to activate gene transcription. As described in our previous report (Jiang et al., 2005) , HIF-1a is able to interact with and enhance the transcriptional activity of C/EBPa. Thereby, it is reasonable to speculate that under hypoxia, physical and functional interactions between Runx1, C/EBPa and HIF-1a contribute to hypoxia-triggered hematopoietic differentiation.
Taken together, our results support that interaction of HIF-1a with Runx1 presents dual effects. On the one hand, Runx1 inhibits transcriptional activity of HIF-1, which helps to produce low-oxygen microenvironment of bone marrow due to inhibition of angiogenesis. On the other hand, HIF-1 increases transcriptional activity of Runx1 and also C/EBPa, which promotes differentiation of leukemic cells. Further investigations into functional significances of these protein-protein interactions would shed new insight to understanding Runx1 and HIF-1a-related hematopoietic cell differentiation and angiogenesis.
Materials and methods
Cells and plasmids
Leukemic cell line U937 and the non-hematopoietic cell lines Cos-7 and HeLa were respectively cultured in RPMI-1640 and Dulbecco's modified Eagle's medium (Sigma, St Louis, MI, USA) supplemented with 10% fetal bovine serum (FBS, Hyclone, Logan, UT, USA) in a humidified incubator at 371C and 5% CO 2 /95% air. A03_1 cell line was cultured in hypoxanthine or thymidine and phenol red-free F-12 Ham's medium with 0.3 mM methotrexate and 10% dialysed FBS (Li et al., 1998; Stenoien et al., 2001) . Hypoxic treatment was performed in a specially designed hypoxia incubator (Thermo Electron, Forma, MA, USA) with 2% air, 5% CO 2 and 93% N 2 . All plasmids used in this work were described in the attached Supplementary materials.
Fluorescent and deconvolution microscopy CFP-LacR-HIF-1a and YFP-Runx1 vectors were transiently transfected into A03_1 cell line by GeneJuice reagent (Novagen, Nottingham, UK) (Dong et al., 2004) . Deconvolution microscopy was performed with a Zeiss AxioVert S100 TV microscope and a DeltaVision Restoration Microscopy System (Applied Precision) as described previously (Stenoien et al., 2001) . A Z-series of focal plane was digitally imaged and deconvolved with the DeltaVision constrained iterative algorithm to generate high-resolution images.
Co-immunoprecipitation
Cell extracts were incubated with mouse monoclonal antibody against HIF-1a (Becton Dickinson, Palo Alto, CA, USA) and Runx1 (N-20, Santa Cruz Biotech, Santa Cruz, CA, USA) together with protein A plus-agarose (Santa Cruz Biotech) or incubated with mouse anti-Flag M2-agarose gel (Sigma) overnight at 41C. Normal preimmune mouse and goat IgG (Santa Cruz Biotech) were also used as negative controls. The immunoprecipitates were eluted by the 2 Â sodium dodecyl sulphate (SDS) sample buffer and then detected by western blots.
GST pull-down assay
The GST alone and GST-tagged full-length or truncated Runx1 fusion protein were expressed in E. coli BL21 and purified by the Bulk GST Purification Module according to the manufacturer's instructions (Amersham Biosciences, Buckinghamshire, UK). The purified proteins were subject to blot with anti-GST antibody (Amersham Biosciences) or were incubated with HIF-1a protein translated in vitro using the TNT T7 Transcription/Translation System (Promega, Madison, WI, USA) for 2 h at room temperature, followed by western blot with anti-HIF-1a antibody (Becton Dickinson).
Electrophoretic gel mobility shift assay Nuclear extracts were used for EMSA, which was described in Supplementary materials.
Luciferase assay
HeLa cells were seeded in 12-well plate (Becton Dickinson, Franklin Lakes, NJ, USA), and then co-transfected either by pFlag-Runx1 (250 ng) together with pGL3-EpoHRE-Luc (100 ng) and pSV40-Renilla (10 ng) for the analysis of the transcriptional activity of HIF-1a, or by CBF-b, pFlag-CMV4-Runx1 and/or pEF-BOS-HIF-1a (250 ng each) with pM-CSFR-Luc (50 ng) and pSV40-Renilla (0.5 ng) for transcriptional activity of Runx1. The empty vectors were supplemented with 800 ng of the total plasmid concentration. Twenty-four hours later, the cells were cultured in 2 and 95% air for additional 24 h. Then, the cell lysates were analysed by the Dual-Luciferase Assay system (Promega) according to the manufacturer's instructions.
Real-time quantitative RT-PCR Total RNA was isolated by TRIzol kit (Invitrogen, Scotland, UK) with DNase (Promega) treatment, and cDNA was synthesized by the cDNA synthesis kit (Roche-Applied Biosystems, Foster, CA, USA). Quantitative real-time PCR was performed using the SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK) on the ABI PRISM 7900 system (Perkin-Elmer, Torrance, CA, USA). The primers used were provided in Supplementary materials. b-actin was used as an internal control. All amplification and detection were carried out in a MicroAmp optical 384-well reaction plate with optical adhesive covers (Applied Biosystems, Foster, CA, USA) and data were analysed by using the ABI PRISM SDS 2.0 softerware (Zhao et al., 2004) .
siRNA design and stable expression Three pairs of complementary oligonucleotides against Runx1 as follows were synthesized, annealed and ligated into mammalian expression vector, pSilencer 3.1-H1 neo according to the manufacturer's construction (Ambion, Austin, TX, USA): A1: 5 0 -GATCCCGTGCATACTTGGAAT GAATCT TCAAGAGAGATTCATTCCAAGTATGCATTTTTTGGA AA-3 0 (forward strand) and 5 0 -AGCTTTTCCAAAAAAT GCATACTTGGAATGAATCTCTCTTGAAGATTCATTCC AAGTATGCACGG-3 0 (reverse strand); A2: 5 0 -GATCCCGT GAATCCTTCTAGAGACGTT TCAAGAGAACGTCTC TAGAAGGATTCATTTTTTGGAAA-3 0 (forward strand) and 5 0 -AGCTTTTCCAAAAAATGAATCCTTCTAGAGA CGTTCTCTTGAAACGTCTCTAGAAGGATTCACGG-3 0 (reverse strand); A3: 5 0 -GATCCCGCCAGGTTGCAAGAT TTAATTT CAAGAGAATTAAATCTTGCAACCTGGTTT TTTGGAAA-3 0 (forward strand) and 5 0 -AGCTTTTCCA AAAAACCAGGTTGCAAGATTTAATTCTCTTGAAATT AAATCTTGCAACCTGGCGG-3 0 (reverse strand). These siRNA-containing vectors and negative control pSilencer neo vector were respectively transfected into U937 cells using Gene Pulser Xcellt Eukaryotic System (Bio-Rad, Hercules, CA, USA). Forty-eight hours later, 500 mg/ml of G418 (Sigma) were added to filtrate the stable transfected cells.
Western blot
Proteins were fractionated on a 10% SDS-polyacrylamide gel, and transferred to the Hybondt-C Extra nitrocellulose membrane (Amersham Biosciences), the latter being incubated with the indicated primary antibodies, followed by horseradish peroxidase (HRP)-linked secondary antibodies (Cell Signaling, Beverly, MA, USA). Detection was performed by chemiluminescence phototope-HRP kit (Cell Signaling). Blots with anti-b-actin antibody (NeoMarkers, Fremont, CA, USA) were also used as equal loading controls.
Statistical analysis
Student's t-test was used to compare the difference between two groups. A value of Po0.05 was considered to be statistically significant.
